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Background: Hypertrophic cardiomyopathy (HCM) is underscored by profound phenotypic and genotypic heterogeneity. Echocardiographically, 
HCM can be categorized in 4 different morphological subtypes: reverse curve-, sigmoidal-, neutral contour-, and apical variant-HCM. Previous studies 
indicate that reverse curve-HCM is the strongest single predictor of a positive genetic test. Much less is known about the genotypic and phenotypic 
spectrum associated with apical-HCM. 
methods: Between 1999 and 2007, 1053 unrelated patients with the clinical diagnosis of HCM (60% male, age at diagnosis 44.4 ± 19 years) 
underwent sarcomeric HCM genetic testing. Blinded to the genetic test results, each echocardiogram was scored for septal morphology and 
phenotyping was performed using the patient’s electronic medical record. 
results: Overall, 70 patients (7%) had apical-HCM on echocardiography; 64% of these patients were male with average age at diagnosis of 47.5 
± 15 years and mean left ventricular wall thickness of 19.8 ± 6 mm. As expected, left ventricular outflow tract obstruction was uncommon (7; 10%). 
Seventeen patients (24%) had a positive genetic test with the majority of mutations found in MYBPC3 (6; 35%) and MYH7 (6; 35%). Two patients 
(12%) had more than 1 mutation, 2 patients (12%) had a mutation in TNNI3 and 1 (6%) in TNNC1. Compared to patients with reverse curve-HCM, 
patients with apical-HCM were older at diagnosis (47 ± 15 vs. 36.8 ± 19 years; p<0.001) and were less likely to have a positive family history of 
HCM (30% vs. 46%; p=0.02) which was reflected in a significantly lower yield of genetic testing for patients with apical-HCM (24%) compared to 
patients with reverse curve-HCM (59%, p < 0.0001). 
conclusions: In this largest cohort of unrelated patients with genetic testing for clinically diagnosed HCM, <10% exhibited apical variant disease. 
This least common morphological subtype of HCM was associated with a negative genetic test result over 75% of the time. In contrast to prior 
publications suggesting a predilection for ACTC1/TPM1 mutations in patients with apical-HCM, the two most common HCM genotypes (MYBPC3- and 
MYH7-HCM) remained most common among the minority who had a positive genetic test.
